Publication | Closed Access

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial

ThrombosisTenecteplase Versus AlteplaseCardiovascular DiseaseIschemic StrokeMedicineOutcomes ResearchCerebrovascular DiseaseBrain InjuryNeurologyRehabilitationNon-inferiority TrialCerebral Blood FlowPublic HealthStrokeCerebrovascular InterventionAtherosclerosisIschemic SyndromePhase 3